Description of a Cohort with a New Truncating MYBPC3 Variant for Hypertrophic Cardiomyopathy in Northern Spain
Genes · 2023
DOI: 10.3390/genes14040840 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2023. Verfasst von Natalia Fernández Suárez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Cardiology Division, Pediatric Department, "Marqués de Valdecilla" University Hospital, 39008 Santander, Spain. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The pathogenicity of the different genetic variants causing hypertrophic cardiomyopathy (HCM) and the genotype/phenotype correlations are difficult to assess in clinical practice, as most mutations are unique or identified in non-informative families. Pathogenic variants in the sarcomeric gene MYBPC3 inherited with an autosomal dominant pattern, whereas incomplete and age-dependent penetrance are the most common causes of HCM.
Methods
We describe the clinical characteristics of a new truncating MYBPC3 variant, p.Val931Glyfs*120, in 75 subjects from 18 different families from northern Spain with the p.Val931Glyfs*120 variant.
Results
Our cohort allows us to estimate the penetrance and prognosis of this variant. The penetrance of the disease increases with age, whereas 50% of males in our sample developed HCM by the age of 36 years old, and 50% of women developed the disease by the time they reached 48 years of age (p = 0.104). Men have more documented arrhythmias with potential risk of sudden death (p = 0.018), requiring implantation of cardioverter defibrillators (p = 0.024). Semi-professional/competitive sport among males is related to earlier onset of HCM (p = 0.004).
Conclusions
The p.Val931Glyfs*120 truncating variant in MYBPC3 is associated with a moderate phenotype of HCM, with a high penetrance, onset in middle age, and a worse outcome in males due to higher risk of sudden death due to arrhythmias.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Cardiology Division, Pediatric Department, "Marqués de Valdecilla" University Hospital, 39008 Santander, Spain.
- Cardiovascular Genetic Disease Division, Molecular Genetic Department, "Marqués de Valdecilla" University Hospital, 39008 Santander, Spain.
- Pediatric Laboratory, Department of Medical and Surgical Sciences, Faculty of Medicine, University of Cantabria, 39011 Santander, Spain.
- Familial Heart Disease Division, Cardioloy Department, "Marqués de Valdecilla" University Hospital, 39008 Santander, Spain.
- Pediatric Nephrology, Metabolism and Genetic Disease Division, Pediatric Department, "Marqués de Valdecilla" University Hospital, 39008 Santander, Spain.
- Research Institute Valdecilla (IDIVAL), 39011 Santander, Spain.
ORCID-Profile: Natalia Fernández Suárez, María Esther Onecha de la Fuente
Zitieren
APA
Fernández Suárez, N., Viadero Ubierna, M. T., Garde Basas, J., Onecha de la Fuente, M. E., Amigo Lanza, M. T., Martin Gorria, G., Rivas Pérez, A., Ruiz Guerrero, L., & González-Lamuño, D. (2023). Description of a Cohort with a New Truncating MYBPC3 Variant for Hypertrophic Cardiomyopathy in Northern Spain. Genes. https://doi.org/10.3390/genes14040840
Vancouver
Fernández Suárez N, Viadero Ubierna MT, Garde Basas J, Onecha de la Fuente ME, Amigo Lanza MT, Martin Gorria G, et al. Description of a Cohort with a New Truncating MYBPC3 Variant for Hypertrophic Cardiomyopathy in Northern Spain. Genes. 2023. doi:10.3390/genes14040840
BibTeX
@article{FernndezSurez2023,
author = {Fernández Suárez, Natalia and Viadero Ubierna, María Teresa and Garde Basas, Jesús and Onecha de la Fuente, María Esther and Amigo Lanza, María Teresa and Martin Gorria, Gonzalo and Rivas Pérez, Adrián and Ruiz Guerrero, Luis and González-Lamuño, Domingo},
title = {Description of a Cohort with a New Truncating MYBPC3 Variant for Hypertrophic Cardiomyopathy in Northern Spain},
journal = {Genes},
year = {2023},
doi = {10.3390/genes14040840}
}
EUVIMED